Stocks

The table gives an overview of all stocks, alphabetically sorted.
 H&D Wireless Sweden Holding B HDWB Mar 3, 2021 0.52 0.00   
 H&M B HMB Mar 3, 2021 203.20 +1.09   
 Hafnia Limited HAFNIO Mar 3, 2021 16.48 0.00   
 Haldex HLDX Mar 3, 2021 48.95 +1.35   
 Halmslätten HALMEN Mar 3, 2021 104.00 0.00   
 Hamlet Pharma HAMLET Mar 3, 2021 19.96 -0.20   
 Handelsbanken A SHBA Mar 3, 2021 92.06 +1.32   
 Handelsbanken B SHBB Mar 3, 2021 104.40 +1.36   
 Handicare Group HANDI Mar 3, 2021 49.60 +0.61   
 Hansa Biopharma HNSA Mar 3, 2021 155.00 -1.65   
 HANZA Holding HANZA Mar 3, 2021 15.60 -0.64   
 Havila Shipping HAVIO Mar 3, 2021 2.94 0.00   
 Havsfrun Investment HAVS Mar 3, 2021 23.50 +2.17   
 Havsfrun Investment B HAVB Mar 3, 2021 23.50 +2.17   
 Havyard Group HYARDO Mar 3, 2021 21.10 0.00   
 Heba B HEBAB Mar 3, 2021 106.50 -0.93   
 Hedera Group HEGR Mar 3, 2021 4.46 +5.69   
 Heimstaden Pref HEIMPREF Mar 3, 2021 342.00 -0.87   
 Heliospectra HELIO Mar 3, 2021 3.50 +6.22   
 Hemcheck Sweden HEMC Mar 3, 2021 3.68 -0.54   
 Herantis Pharma HRNTS Mar 3, 2021 33.00 -2.08   
 Hexagon B HEXAB Mar 3, 2021 728.80 -0.05   
 Hexagon Composites HEXO Mar 3, 2021 54.00 +5.88   
 Hexatronic Group HTRO Mar 3, 2021 104.00 +1.76   
 Hexpol B HPOLB Mar 3, 2021 93.75 +1.79   
 Hifab B HIFAB Mar 3, 2021 2.96 +0.68   
 HMS Networks HMS Mar 3, 2021 310.50 +0.32   
 Hofseth BioCare HBCO Mar 3, 2021 8.74 0.00   
 Hoist Finance HOFI Mar 3, 2021 42.82 +0.52   
 Holmen A HOLMA Mar 3, 2021 402.00 +0.50   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK